Introduction
Mouse infections with Salmonella typhimurium and S. enteritidis have been studied as a model of S. typhi infections in humans. It is knwon that living vaccines induce a cellular immune response, and are more effective than non-viable vaccines for the induction of immunity to Salmonella infectionslo. However, there are many reports showing that non-viable vaccines give excellent levels of protection as compared with living vaccines3)-5).
Earlier studies in this laboratory have shown that immunization with Soluble Protective Antigen (SPA) separated from the culture fluids of S. enteritidis strain 2547 induced high levels of resistance against the challenge of 10,000 LD50 of the same organism strain6). The protective capacity of SPA has been attributed to the ability to elicit both a cellular and humoral immune response in the host7)8). In previous studies, chemical and biological analyses of SPA indicated that SPA contains a lipid A moiety, and possesses the properties of lipopolysaccharides (LPS) isolated from S. enteritidis by chemical procedures"). However, the LPS from S. enteritidis strain 2547 afforded only 80% protective immunity against the challenge of 100 LD50 of the homologous bacteria. These results suggested that SPA differs markedly in physiochemical capabilities from the LPS isolated by chemical procedures, although it is certainly part of the LPS released into the liquid environment by solubilization of bacterial cell wall material. In the present study, cross-protection tests against the challenge of different strains of CF from S. enteritidis were conducted to determine whether protective antigen (SPA) is released only from strain 2547 into the culture fluid. Further comparisons were made concerning the ability of inducing protective 
